ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
48 announcements
Consolidated Q2 net profit jumped 193% to ₹33.9 Cr off a weak base, but H1 revenue rose only 2% and standalone EBITDA was flat. Margin recovery depends on input costs normalising, which management hopes for but does not guide.
MOL reported Q2 FY27 revenue of ₹658.2 crore, up 18% YoY, with net profit of ₹45.3 crore. EBITDA margin eased to 10.8% on elevated input costs.
Q2 FY27 standalone revenue ₹658.2 Cr (+18% YoY), EBITDA flat at ₹70.9 Cr, margin 10.8% under cost pressure; PAT ₹45.3 Cr (+6%). Strategy: TiO2 import substitution and nano fertiliser expansion.
Meghmani Organics Ltd reported revenue from operations of ₹666.9 Cr (+15.5% YoY) and net profit of ₹33.9 Cr (+192.2% YoY) for Q2 FY27.
India Ratings assigned Meghmani Organics' bank loan facilities of INR 11,000 million a rating of IND A/Stable/IND A1. The filing encloses the rating letter and a facilities breakup.
Meghmani Organics will hold a board meeting on 4 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The meeting is a future notice, so no results are yet reported.
Meghmani Organics Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended September 30, 2026.
Meghmani Organics Limited received an NCLT Ahmedabad Bench order sanctioning the Scheme of Amalgamation of its wholly-owned subsidiaries, Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited, with itself.
Meghmani Organics Limited held its 7th Annual General Meeting on September 8, 2026. The meeting concluded successfully with all items of business transacted as proposed.
Meghmani Organics Limited has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26. The report details environmental, social, and governance initiatives.
Meghmani Organics Limited has released its Annual Report for FY 2025-26. The 7th Annual General Meeting is scheduled for September 8, 2026, via video conferencing.
Meghmani Organics Limited has scheduled its 7th Annual General Meeting for September 8, 2026. The company also announced a book closure period for this meeting.
Meghmani Organics Q1 FY27 revenue fell 12% YoY to INR542cr, but consolidated PAT jumped 280% to INR48.2cr on improved margins and operational efficiencies.
Meghmani Organics Limited has appointed Mr. Naresh Prajapati as the Company Secretary and Key Managerial Personnel, effective July 29, 2026.
Meghmani Organics reported Q1 FY27 consolidated revenue of ₹542.8 Cr, down 12% YoY, while EBITDA grew 46% to ₹97.9 Cr. Performance was driven by improved product mix despite macroeconomic uncertainties.
Meghmani Organics reported Q1 FY27 revenue of ₹522.9 Crore. Net profit rose 42% YoY to ₹57.6 Crore despite macroeconomic uncertainties.
Meghmani Organics Ltd reported revenue from operations of ₹542.8 Cr (-11.5% YoY) and net profit of ₹48.2 Cr (+279.5% YoY) for Q1 FY27.
Meghmani Organics Limited scheduled a board meeting on July 29, 2026, to consider and approve standalone and consolidated financial results for the quarter ended June 30, 2026.
Meghmani Organics clarified that the significant volume movement in its shares is purely market-driven. The company maintains it has no control over these movements.
Meghmani Organics shareholders approved the amalgamation of Kilburn Chemicals and Meghmani Crop Nutrition. The resolution passed with 99.99% majority in an NCLT-convened meeting.
Meghmani Organics Limited conducted an NCLT-convened meeting to approve the amalgamation of two wholly-owned subsidiaries. The move aims to simplify group structure and enhance operational synergies.
Meghmani Organics Limited filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms full compliance with SEBI regulations and listing norms.
Meghmani Organics reported FY26 standalone revenue of ₹2,091cr (up 4% YoY) and EBITDA of ₹228.7cr (up 27% YoY). Strategy focuses on Brazil expansion and Nano-fertilizer growth.
Meghmani Organics reported FY26 revenue of ₹2,091.8 Crore, up 4% YoY. Despite macroeconomic headwinds impacting Q4, the company expanded its Crop Nutrition portfolio with three new products.
Meghmani Organics reported FY26 consolidated revenue of ₹2,174 Cr, up 5% YoY, with PAT at ₹28.7 Cr. The company is pivoting towards high-margin Crop Nutrition (Nano Urea) and Titanium Dioxide segments.
Meghmani Organics Limited announced the resignation of Company Secretary Jayesh Ravjibhai Patel, effective May 23, 2026. The departure for personal reasons triggers a senior management transition.
Meghmani Organics Ltd reported revenue from operations of ₹474.3 Cr (-14.3% YoY) and net profit of ₹8 Cr (-59.6% YoY) for Q4 FY26.
Meghmani Organics Limited reported its audited financial results for the fiscal year ended March 31, 2026. The board also approved a scheme for amalgamating two subsidiaries.
Meghmani Organics Limited has re-scheduled its board meeting to May 14, 2026, to approve audited financial results for FY2026. The meeting was postponed from May 9 due to an NCLT-convened meeting regarding a Scheme of Amalgamation. The trading window remains closed until May 16, 2026.
Meghmani Organics Limited has re-scheduled its Board Meeting to May 14, 2026. The board will consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.